Strategy that helped drive down rate of HIV/AIDS being used to tackle BC’s overdose crisis


An 18-month pilot project is being expanded across British Columbia – after more than double the number of drug-addicted people stayed in treatment to stop them from fatally overdosing.

The initiative, led by the BC Centre for Excellence in HIV/AIDS and Vancouver Coastal Health, uses the same strategy that helped drive down the province’s HIV and AIDS rates.

The pilot at 17 clinics in Vancouver involved 1,100 patients and showed seven out of 10 of them stayed in treatment after three months, up from three people, as part of a program that prescribes substitute opioids to curb drug cravings and ward off withdrawal symptoms.

Guest: Cole Stanley

Medical Lead for the BOOST Initiative, led by the BC Centre for Excellence

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below